English to Spanish Medical Medical: Pharmaceuticals live

Noninferiority of IncobotulinumtoxinA Compared with OnabotulinumtoxinA for Treatment of Glabellar Lines
Secondary endpoint1

Responder Rates*,† at Rest Assessed by the Independent Raters (from Digital Photographs) and Assessed Live by the Investigator

* Responder defined as improvement of ≥ 1 point on 4-point FWS; † Analyses conducted on the per protocol set: incobotulinumtoxinA, N = 277; onabotulinumtoxinA, N = 93.
incobotA = incobotulinumtoxinA = Bocouture; onabotA = onabotulinumtoxinA = Vistabel; FWS = facial wrinkle scale.
Results from comparative studies may be influenced by differences in dose, study design, frequency of follow-up, patient population in which the drug is studied, and sensitivity of rating scales. Comparisons are not intended to suggest any clinical benefit of one product over another.

Muchas gracias.